English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Csl Behring
Carol Ostrow
| Dec 16, 2017
CSL partners with Vitaeris for organ transplant therapy
Carol Ostrow
| Sep 29, 2017
CSL Behring pledges $4.92 million for Penn State biotechnology center
Erianne Leatherman
| Apr 18, 2017
CSL Behring honors World Hemophilia Day with medications donation
Erianne Leatherman
| Apr 14, 2017
CSL Behring awards grants to four groups to boost support for patients with rare diseases
Erianne Leatherman
| Apr 12, 2017
CSL Behring to sponsor Jeffrey Modell North African Network for primary immunodeficiency
Jeff Gantt
| Dec 18, 2016
Afstyla approved by Health Canada
Amanda Rupp
| Jun 22, 2016
CSL Behring honors 2016 HAE Day with events
Amanda Rupp
| Jun 1, 2016
Afstyla gains FDA approval as hemophilia A treatment
Trending
+
Marketing
Patient Daily
| Sep 17, 2025
Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+
Pharmaceuticals
Patient Daily
| Sep 23, 2025
Wall Street Journal editorial board alleges hospitals misuse 340B program
+
Regulatory
Patient Daily
| Sep 17, 2025
PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'
+
Pharmaceuticals
Patient Daily
| Sep 22, 2025
Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
